Skip to main content
. 2021 Nov 18;43(5):3211–3221. doi: 10.1007/s10072-021-05723-z

Table 2.

Change in Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised overall score and subdomain scores and in forced vital capacity, at treatment end (assessment performed at week 25) and end of follow-up in the evaluable population

Parameter Baseline (n = 13) Week 25 (n = 11) Week 48 (n = 10)
Change from baseline p value Change from baseline p value
ALSFRS-R overall, median (IQR) 42.0 (37.0, 44.0)  − 4.0 (− 8.0, − 3.0) 0.0010  − 10.0 (− 14.0, − 7.0)  < 0.0001
ALSFRS-R bulbar, median (IQR) 10 (9.0, 12.0) 0.0 (− 2.0, 0.0) 0.2500 2.0 (− 4.0, 0.0) 0.0313
ALSFRS-R fine and gross motor, median (IQR) 19.0 (17.0, 21.0)  − 3.0 (− 5.0, − 3.0) 0.0010  − 7.0 (− 9.0, − 5.0)  < 0.0001
ALSFRS-R respiratory, median (IQR) 12.0 (12.0, 12.0) 0.0 (− 2.0, 0.0) 0.1875 0.0 (− 4.0, 0.0) 0.0625
FVC (L), median (IQR) 3.9 (3.0, 4.9)  − 0.4 (− 0.8, 0.0) 0.0413  − 0.9 (− 1.8, − 0.3) 0.0155
FVC as % of predicted, median (IQR) 87.0 (76.0, 96.0)  − 9.0 (− 23.0, − 6.0) 0.0068  − 23.0 (− 38.0, − 9.0) 0.0006

ALSFRS-R scores: overall score ranges from 0 (worst) to 48 (best). Lower scores indicate worse ability; higher scores indicate better ability. p-values in bold stands for p < 0.05

ALSFRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale- Revised; FVC, forced vital capacity; IQR, interquartile range